IVF market seen reaching $55.94B by 2035

The global in-vitro fertilization market is projected to grow from $26.65 billion in 2025 to $55.94 billion by 2035, driven by older maternal age, rising infertility, broader reimbursement and faster lab automation. North America leads today, while Asia-Pacific is forecast to grow the fastest.

Why it matters: - The IVF market is moving from a niche fertility service into a larger, more standardized healthcare category. - Demand is rising as infertility becomes more common, employer benefits expand and public reimbursement widens in key markets. - The shift could lift spending on fertility clinics, lab equipment, media, genetic testing and cryopreservation infrastructure.

What happened: - Market Research Future projects the global in-vitro fertilization market will reach $55.94 billion by 2035, up from $26.65 billion in 2025. - The forecast implies a 7.70% compound annual growth rate from 2026 through 2035. - The market closed 2025 at roughly $26.65 billion. - The estimate was released Sept. 8, 2026. - Request a free sample of the report. - Read the detailed report.

The details: - Rising maternal age at first birth and growing infertility prevalence are central demand drivers. - The World Health Organization estimates roughly one in six adults worldwide experiences infertility. - Employer-funded fertility benefits are expanding, with about 47% of large U.S. employers now covering fertility care. - Japan has added assisted reproductive technology to national health insurance. - Laboratory automation is advancing through time-lapse imaging, AI-assisted embryo grading and vitrification protocols. - Vitrification has almost fully replaced slow-freeze methods. - Preimplantation genetic testing now appears in about one-third of cycles in mature markets. - Frozen IVF cycles are advancing at a 9.4% CAGR as freeze-all protocols become standard practice. - Reagents and media are the largest product segment, with a 41.8% share in 2025. - Instruments were valued at $9.67 billion in 2025. - Consumables and disposables are the fastest-growing product segment at an 8.3% CAGR. - Fresh IVF cycles, non-donor, held the largest cycle-type share at 36.2% in 2025. - Frozen IVF cycles, non-donor, are the fastest-growing cycle type at a 9.4% CAGR. - Fresh donor cycles were valued at $4.61 billion in 2025. - IVF with ICSI led procedure types with a 45.6% share in 2025. - Conventional IVF was valued at $7.44 billion in 2025. - IVF with PGT/PGD is the fastest-growing procedure type at a 10.2% CAGR. - Fertility clinics dominated end users with a 68.4% share in 2025. - Hospitals were valued at $5.12 billion in 2025. - Clinical research institutes are the fastest-growing end-user segment at an 8.9% CAGR.

Between the lines: - The market is being shaped by a move toward higher-value cycles and more data-heavy workflows. - AI-based embryo ranking and digital clinic dashboards are becoming competitive tools, not just technical add-ons. - Coverage expansion matters as much as clinical innovation because IVF demand is highly sensitive to out-of-pocket costs. - The report points to a broader consolidation trend, with clinics standardizing procurement and outcomes around larger platforms. - Vitrolife, CooperSurgical and Merck KGaA are using software, integration and digital analytics to differentiate beyond hardware.

What's next: - North America is expected to keep leading on revenue, with 38.5% of global revenue in 2025 and about $10.26 billion in market value. - Asia-Pacific is projected to grow the fastest at a 9.6% CAGR. - Europe remains the second-largest region at $7.20 billion in 2025. - The Middle East and Africa market was valued at about $0.93 billion in 2025 and is still early in its growth curve. - Market Research Future expects emerging-market expansion, AI-assisted embryo selection, cryostorage investment and clinic consolidation to shape the next growth phase.

The bottom line: - IVF is being pulled forward by demographics, reimbursement and technology, with the market on track to more than double by 2035.